This you?

  • You work in life sciences

  • You need to understand large molecules, like antibodies

  • You want to be spoon-fed the information, because frankly, you are busy

What will I learn?

  • What is a large molecule drug?

    Learn the difference between a large molecule drug and a small molecule drug. Learn the features and characteristics of peptides and antibodies.

  • How are antibodies discovered?

    Learn how antibodies are discovered to treat a particular disease or disorder and how antibodies are manufactured.

  • How are large molecules approved?

    Learn the approval process for large molecule drugs and the reasons why large molecules fail in the clinic.

How will I learn?

This Large Molecule Drug course includes 7 lessons to cover how large molecules are discovered to how large molecule drugs are approved and marketed.

  • 7 videos

  • 7 quizzes

  • 7 downloadable notes

Large Molecule Drugs

Course curriculum

  • 1
    Large Molecule Market
    • Video: Large Molecule Market
    • PDF (slides): Large Molecule Market
    • Quiz: Large Molecule Market
  • 2
    Introduction to Peptides
    • Video: Introduction to Peptides
    • PDF (slides): Introduction to Peptides
    • Quiz: Introduction to Peptides
  • 3
    Introduction to Antibodies
    • Video: Introduction to Antibodies
    • PDF (slides): Introduction to Antibodies
    • Quiz: Introduction to Antibodies
  • 4
    Antibodies in the body
    • Video: Antibodies in the body
    • PDF (slides): Antibodies in the body
    • Quiz: Antibodies in the body
  • 5
    Making Antibodies
    • Video: Making Antibodies
    • PDF (slides): Making Antibodies
    • Quiz: Making antibodies
  • 6
    Antibody Drug Discovery
    • Video: Antibody Drug Discovery
    • PDF (slides): Antibody Drug Discovery
    • Quiz: Antibody Drug Discovery
  • 7
    Peptides and Antibodies as Therapeutics
    • Video: Peptides and Antibodies as Therapeutics
    • PDF (slides): Peptides and Antibodies as Therapeutics
    • Quiz: Peptides and Antibodies as Therapeutics

Large molecules in the news

July 19, 2021

Alector and GlaxoSmithKline (GSK) have established a partnership to develop two investigational antibodies  to boost the production of the progranulin protein as a potential treatment for neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS).

Follow our life science blog here